Age-related decrease in bone mass: Disrupted microarchitecture
Male: female ratio is 1:4
Can lead to fractures: vertebral body > hip > wrist fractures
wrist fractures occur most commonly at age 50-60 years
vertebral fractures occur most commonly at age 60-70 years
hip fractures occur most commonly at age 70-80 years
Treatment
Life style modification : smoking, alcohol, physical acitivty, weight loss
Vit D, Calcium.
Daily calcium and Vitamin D requirements are as follows:
Age 1-3yrs - 500mg/d
Age 4-8yrs - 800mg/d
Age 9-18yrs - 1000 to 1500mg/d
Age >50 yrs- 1200 to 1500 mg/d calcium
800-1,000 IUs Vit. D
Biphosphonate
Indication
T-score <2.5 at the femoral neck or spine (after exclusion of secondary causes)
low bone mass (T-score between -1.0 and -2.5) and
10-year probability of a hip fracture ≥ 3% or greater or
10-year probability of a major osteoporosis-related fracture ≥ 20% based on WHO algorithm
Oral : pamidronate, alendronate (Fosamax), risedronate (Actonel), zolendronate (Reclast), ibandronate (Boniva)
IV
side effects: Esophagitis, dysphagia, gastric ulcers, Osteonecrosis of the Jaw, atypical hip fracture (Sub-trochanteric) if taken for long time
Teriparatide (Forteo)
1-34 amino terminal residues of parathyroid hormone (1-84)
given by daily subcutaneous injections in case of Severe osteoporosis/high fracture risk or vertebral fracture
can induce transcient hypercalcemia, dizziness, nausea, headache
contre indicated in Paget disease : Sarcoma
cumulative dose: 2 years (risk of sarcoma)
Denosumab (Prolia)
Monoclonal Ig2 against RANKL (inhibits binding of RANKL to RANK)
given 1 injection of 60mg every 6 months
For Postmenopausal women at high risk of fracture
side effects : nasopharyngitis, back pain, mandubular osteonecrosis ( ask for dental hygiene)
contre indicated in severe hypocalcemia ( pay attention in case of renal diffiency)